Watson James F
SEC-identified person · CIK 1420406 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pharmathene, INC PIP | Officer | filed 2020 - 2020 |
| Vyne Therapeutics Inc. VYNE | Officer | filed 2018 - 2018 |
| Neos Therapeutics, Inc. NEOS | Officer | filed 2015 - 2016 |
| Intermolecular INC IMI | Director | filed 2011 - 2014 |
| Tetraphase Pharmaceuticals INC TTPH | Officer | filed 2013 - 2013 |
| Entropic Communications INC ENTR | Officer | filed 2007 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.